These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccines as a global imperative--a business perspective. Stéphenne J Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955 [TBL] [Abstract][Full Text] [Related]
3. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme. Kaljee LM; Pack R; Pach A; Nyamete A; Stanton BF J Health Popul Nutr; 2004 Sep; 22(3):293-303. PubMed ID: 15609782 [TBL] [Abstract][Full Text] [Related]
5. Drugs and vaccines around the world. Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572 [No Abstract] [Full Text] [Related]
6. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more. Hotez P Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960 [TBL] [Abstract][Full Text] [Related]
7. Introducing new vaccines into developing countries: obstacles, opportunities and complexities. Clemens J; Jodar L Nat Med; 2005 Apr; 11(4 Suppl):S12-5. PubMed ID: 15812482 [TBL] [Abstract][Full Text] [Related]
8. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries. Jadhav S; Datla M; Kreeftenberg H; Hendriks J Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742 [TBL] [Abstract][Full Text] [Related]
9. Can needle-free administration of vaccines become the norm in global immunization? Levine MM Nat Med; 2003 Jan; 9(1):99-103. PubMed ID: 12514720 [No Abstract] [Full Text] [Related]
10. The problems and promise of vaccine markets in developing countries. Batson A Health Aff (Millwood); 2005; 24(3):690-3. PubMed ID: 15886160 [TBL] [Abstract][Full Text] [Related]
11. Progress towards millennium development goals for TB control in seven Asian countries. Chadha VK Indian J Tuberc; 2009 Jan; 56(1):30-43. PubMed ID: 19402270 [No Abstract] [Full Text] [Related]
12. World Bank espouses public health for those in poverty. Greene S Nature; 1993 Jul; 364(6435):275. PubMed ID: 8332179 [No Abstract] [Full Text] [Related]
13. Reducing the worldwide burden of cancer. Markman M Oncology; 2007; 73(1-2):1. PubMed ID: 18332647 [No Abstract] [Full Text] [Related]
14. Vaccine venture boosts health hopes. Butler D Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588 [No Abstract] [Full Text] [Related]
15. Enhancing global capacity in the surveillance, prevention, and control of chronic diseases: seven themes to consider and build upon. Choi BC; McQueen DV; Puska P; Douglas KA; Ackland M; Campostrini S; Barceló A; Stachenko S; Mokdad AH; Granero R; Corber SJ; Valleron AJ; Skinner HA; Potemkina R; Lindner MC; Zakus D; de Salazar LM; Pak AW; Ansari Z; Zevallos JC; Gonzalez M; Flahault A; Torres RE J Epidemiol Community Health; 2008 May; 62(5):391-7. PubMed ID: 18413450 [TBL] [Abstract][Full Text] [Related]
16. The introduction of new vaccines into developing countries. IV: Global Access Strategies. Mahoney RT; Krattiger A; Clemens JD; Curtiss R Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119 [TBL] [Abstract][Full Text] [Related]
17. The costs of scaling up vaccination in the world's poorest countries. Bishai D; McQuestion M; Chaudhry R; Wigton A Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576 [TBL] [Abstract][Full Text] [Related]